Skip to main content
Erschienen in: Comparative Clinical Pathology 6/2012

01.12.2012 | Original Article

c-erbB2 receptor and P53 protein expression in canine mammary gland carcinoma

verfasst von: Annahita Rezaie, Abbas Tavasoli, Mitra Mehrazma, Alireza Bahonar

Erschienen in: Comparative Clinical Pathology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to investigate the immunohistochemical (IHC) detection of c-erbB2 receptor (crbP) and TP53, the co-expression of these two markers and their relationship with histological type and histological grade in canine mammary carcinoma. After histological diagnosis according to the WHO classification of 30 mammary carcinomas, their histologic grade was identified by the Elston and Ellis method for human breast tumours. Proliferation activity was detected by Ki67 protein. IHC staining was carried out for crbP and TP53 expression. Results of semiquantitative IHC assessment of crbP and 3+ TP53 expression were 23.3% and 53.3% of canine mammary carcinoma, respectively. There were significant relationships between Tp53 and histopathological grade and TP53 and Pki67. No significant results were obtained between crbP and TP53 even with overexpression of TP53 in positive crbP cases. These results suggest that using crbP and TP53 may be useful for malignancy detection accompanied by Pki67, and additional research in this subject is essential.
Literatur
Zurück zum Zitat Ahern JE, Curtis Bird R, Church Bird AE et al (1996) Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell line. Am J Vet Res 57(5):693–696PubMed Ahern JE, Curtis Bird R, Church Bird AE et al (1996) Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell line. Am J Vet Res 57(5):693–696PubMed
Zurück zum Zitat Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI (2007) Spontaneous mammary intraepithelial lesions in dogs—a model of breast cancer. Cancer Epidemiol Biomarkers Prev 16(11):2247–2256PubMedCrossRef Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI (2007) Spontaneous mammary intraepithelial lesions in dogs—a model of breast cancer. Cancer Epidemiol Biomarkers Prev 16(11):2247–2256PubMedCrossRef
Zurück zum Zitat Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756–760PubMedCrossRef Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756–760PubMedCrossRef
Zurück zum Zitat De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF (2005) Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res 65(3):907–912PubMed De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF (2005) Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res 65(3):907–912PubMed
Zurück zum Zitat Dutra AP, Granja NVM, Schmitt FC, Cassali GD (2004) c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz J Med Biol Res 37:1673–1681PubMedCrossRef Dutra AP, Granja NVM, Schmitt FC, Cassali GD (2004) c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz J Med Biol Res 37:1673–1681PubMedCrossRef
Zurück zum Zitat Flint AF, U’ren L, Legare ME, Withrow SJ, Dernell W, Hanneman WH (2004) Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Vet Pathol 41:291–296PubMedCrossRef Flint AF, U’ren L, Legare ME, Withrow SJ, Dernell W, Hanneman WH (2004) Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Vet Pathol 41:291–296PubMedCrossRef
Zurück zum Zitat Hainaut P, Wiman KG (2007) 25 years of P53 research. Springer, Dordrecht, pp 1–20CrossRef Hainaut P, Wiman KG (2007) 25 years of P53 research. Springer, Dordrecht, pp 1–20CrossRef
Zurück zum Zitat Jaffe MH, Hosgood G, Taylor HW, Kerwin SC, Hedlund CS, Lopez MK, Davidson JR, Miller DM, Paranjpe M (2000) Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 37:40–46PubMedCrossRef Jaffe MH, Hosgood G, Taylor HW, Kerwin SC, Hedlund CS, Lopez MK, Davidson JR, Miller DM, Paranjpe M (2000) Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 37:40–46PubMedCrossRef
Zurück zum Zitat Lee CH, Kim WH, Lim JH, Kang MS, Kim DY, Kweon OK (2004) Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J Vet Sci 5(1):63–69PubMed Lee CH, Kim WH, Lim JH, Kang MS, Kim DY, Kweon OK (2004) Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J Vet Sci 5(1):63–69PubMed
Zurück zum Zitat Loukopoulos P, Thornton JR, Robinson WF (2003) Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 40:237–248PubMedCrossRef Loukopoulos P, Thornton JR, Robinson WF (2003) Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 40:237–248PubMedCrossRef
Zurück zum Zitat Martin de las Mulas J, Ordás J, Millán MY, Fernández-Soria V, Ramón y Cajal S (2003) Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study. Breast Cancer Res Treat 80(3):363–367PubMedCrossRef Martin de las Mulas J, Ordás J, Millán MY, Fernández-Soria V, Ramón y Cajal S (2003) Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study. Breast Cancer Res Treat 80(3):363–367PubMedCrossRef
Zurück zum Zitat Milanta F, Calandrella M, Citi S et al (2005) Overexpression of Her-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of prognostic potential. Vet Pathol 42:30–34CrossRef Milanta F, Calandrella M, Citi S et al (2005) Overexpression of Her-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of prognostic potential. Vet Pathol 42:30–34CrossRef
Zurück zum Zitat Minckwitz GV, Sinn HP, Raab G, Loibl S et al (2008) Clinical response after two cycles compared to HER2, Ki67, P53 and bcl2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. Breast Cancer Res 10(2):R30CrossRef Minckwitz GV, Sinn HP, Raab G, Loibl S et al (2008) Clinical response after two cycles compared to HER2, Ki67, P53 and bcl2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. Breast Cancer Res 10(2):R30CrossRef
Zurück zum Zitat Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals, 4th edn. Iowa State Press, Ames, pp 575–606CrossRef Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals, 4th edn. Iowa State Press, Ames, pp 575–606CrossRef
Zurück zum Zitat Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumours of the dog and the cat, vol. VII. Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC, pp 1–59 Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumours of the dog and the cat, vol. VII. Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC, pp 1–59
Zurück zum Zitat Rezaie A, Tavasoli A, Bahonar A, Mehrazma M (2009) Grading in canine mammary carcinoma. J Biol Sci 9:333–338CrossRef Rezaie A, Tavasoli A, Bahonar A, Mehrazma M (2009) Grading in canine mammary carcinoma. J Biol Sci 9:333–338CrossRef
Zurück zum Zitat Rezaie A, Tavasoli A, Mehrazma M, Bahonar A (2010) Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma. Comp Clin Pathol. doi:10.1007/s00580-010-1032-3 Rezaie A, Tavasoli A, Mehrazma M, Bahonar A (2010) Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma. Comp Clin Pathol. doi:10.​1007/​s00580-010-1032-3
Zurück zum Zitat Rungsipipat A, Tateyama S, Yamaguchi R, Uchida K, Miyoshi N, Hayashi T (1999) Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J Vet Med Sci 61(1):27–32PubMedCrossRef Rungsipipat A, Tateyama S, Yamaguchi R, Uchida K, Miyoshi N, Hayashi T (1999) Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J Vet Med Sci 61(1):27–32PubMedCrossRef
Zurück zum Zitat Witton CJ (2003) Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion. Breast Cancer Res 5:206–207PubMedCrossRef Witton CJ (2003) Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion. Breast Cancer Res 5:206–207PubMedCrossRef
Zurück zum Zitat Wolf JC, Ginn IE, Homer B, Fox LE, Kurzman ID (1997) Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors. Vet Pathol 34:394–404PubMedCrossRef Wolf JC, Ginn IE, Homer B, Fox LE, Kurzman ID (1997) Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors. Vet Pathol 34:394–404PubMedCrossRef
Metadaten
Titel
c-erbB2 receptor and P53 protein expression in canine mammary gland carcinoma
verfasst von
Annahita Rezaie
Abbas Tavasoli
Mitra Mehrazma
Alireza Bahonar
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Comparative Clinical Pathology / Ausgabe 6/2012
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-011-1339-8

Weitere Artikel der Ausgabe 6/2012

Comparative Clinical Pathology 6/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …